Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betahistine add-on therapy with olanzapine in schizophrenia: cognition and weight
ChiCTR2100048848Phase 4Completed
- Sponsor
- Peking University Huilongguan Hospital
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of betahistine in schizophrenia, sponsored by Peking University Huilongguan Hospital. Primary endpoint: MCCB. Started Sep 2014; status: completed.
02
Drugs
betahistine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ChiCTR2100048848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048848.